生存期-话题@MedSci

#生存期#

350篇内容 | 3627人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378169, encodeId=55ac13e8169e5, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：胖不胖可能决定透明细胞肾癌患者整体生存期, objectType=article, longId=136030, objectId=c8ac1360301e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ac1360301e, replyNumber=0, likeNumber=76, createdTime=2018-04-22, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ac1360301e, moduleTitle=Radiology：胖不胖可能决定透明细胞肾癌患者整体生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ac1360301e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378168, encodeId=c02613e816839, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：多参数MR成像预测非切除肝内胆管细胞型肝癌生存期的价值, objectType=article, longId=135361, objectId=b2c513536104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b2c513536104, replyNumber=0, likeNumber=29, createdTime=2018-04-16, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b2c513536104, moduleTitle=Radiology：多参数MR成像预测非切除肝内胆管细胞型肝癌生存期的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b2c513536104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378167, encodeId=9f3113e81672f, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Int Oral Max Surg：肿瘤PD-L1的表达与年轻女性口腔鳞状细胞癌生存期的改善及复发风险降低有关, objectType=article, longId=134603, objectId=74e21346033e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74e21346033e, replyNumber=0, likeNumber=120, createdTime=2018-04-10, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74e21346033e, moduleTitle=Int Oral Max Surg：肿瘤PD-L1的表达与年轻女性口腔鳞状细胞癌生存期的改善及复发风险降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=74e21346033e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378166, encodeId=c62c13e81665f, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=索拉非尼可改善纤维瘤患者的无进展生存期, objectType=article, longId=134228, objectId=4eac1342289c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eac1342289c, replyNumber=0, likeNumber=95, createdTime=2018-04-05, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eac1342289c, moduleTitle=索拉非尼可改善纤维瘤患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4eac1342289c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378165, encodeId=310413e8165e1, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Gastroenterology：巴雷特食管患者持续性内镜监控对生存期的影响, objectType=article, longId=130941, objectId=f26013094104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f26013094104, replyNumber=0, likeNumber=106, createdTime=2018-03-02, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f26013094104, moduleTitle=Gastroenterology：巴雷特食管患者持续性内镜监控对生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f26013094104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378164, encodeId=bd0813e8164c7, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J CLIN ONCOL :溶瘤病毒对抗脑瘤！临床1期显示：显著延长患者生存期, objectType=article, longId=130788, objectId=9841130e8875, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9841130e8875, replyNumber=0, likeNumber=75, createdTime=2018-03-01, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9841130e8875, moduleTitle=J CLIN ONCOL :溶瘤病毒对抗脑瘤！临床1期显示：显著延长患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9841130e8875)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378163, encodeId=56b113e816386, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=FDA批准强生前列腺癌新疗法可延长生存期超2年, objectType=article, longId=130592, objectId=0bf3130592e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0bf3130592e5, replyNumber=0, likeNumber=69, createdTime=2018-02-27, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0bf3130592e5, moduleTitle=FDA批准强生前列腺癌新疗法可延长生存期超2年, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0bf3130592e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378162, encodeId=da9813e81629b, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗, objectType=article, longId=130401, objectId=0ffc13040150, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ffc13040150, replyNumber=0, likeNumber=88, createdTime=2018-02-25, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ffc13040150, moduleTitle=Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ffc13040150)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378161, encodeId=8cf213e816141, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JAMA Neurol：1型肌营养不良患者生存期影响因素研究, objectType=article, longId=129753, objectId=f222129e5317, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f222129e5317, replyNumber=0, likeNumber=68, createdTime=2018-02-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f222129e5317, moduleTitle=JAMA Neurol：1型肌营养不良患者生存期影响因素研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f222129e5317)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378160, encodeId=649c13e81609d, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Radiology：DSC MRI中胶质母细胞瘤血管征预测生存期的价值, objectType=article, longId=128594, objectId=6f9212859425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f9212859425, replyNumber=0, likeNumber=90, createdTime=2018-02-03, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f9212859425, moduleTitle=Radiology：DSC MRI中胶质母细胞瘤血管征预测生存期的价值, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f9212859425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378159, encodeId=db5813e8159dc, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Keytruda /化疗组合延长NSCLC患者的生存期, objectType=article, longId=126907, objectId=e4a212690ecc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4a212690ecc, replyNumber=0, likeNumber=58, createdTime=2018-01-20, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4a212690ecc, moduleTitle=Keytruda /化疗组合延长NSCLC患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4a212690ecc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378158, encodeId=85f613e815860, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Circulation：他汀类药物对外周动脉疾病患者截肢和生存期的影响！, objectType=article, longId=126422, objectId=7dc212642262, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dc212642262, replyNumber=0, likeNumber=92, createdTime=2018-01-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dc212642262, moduleTitle=Circulation：他汀类药物对外周动脉疾病患者截肢和生存期的影响！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dc212642262)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378157, encodeId=f79f13e8157c6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期, objectType=article, longId=125691, objectId=29e0125691d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=29e0125691d2, replyNumber=0, likeNumber=84, createdTime=2018-01-07, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=29e0125691d2, moduleTitle=BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=29e0125691d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378156, encodeId=3f9013e8156c8, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=EUR J Cancer：阿司匹林与其他血小板聚集抑制剂对结直肠癌患者生存期的影响, objectType=article, longId=125005, objectId=b837125005d6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b837125005d6, replyNumber=0, likeNumber=82, createdTime=2017-12-30, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b837125005d6, moduleTitle=EUR J Cancer：阿司匹林与其他血小板聚集抑制剂对结直肠癌患者生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b837125005d6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378155, encodeId=6d7c13e815578, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet Respir Med：救护车上给予抗菌药物能延长脓毒症患者的生存期吗？, objectType=article, longId=124739, objectId=739f124e39a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739f124e39a8, replyNumber=0, likeNumber=84, createdTime=2017-12-28, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739f124e39a8, moduleTitle=Lancet Respir Med：救护车上给予抗菌药物能延长脓毒症患者的生存期吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739f124e39a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378154, encodeId=ac7413e81541a, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, objectType=article, longId=123956, objectId=a774123956b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a774123956b5, replyNumber=0, likeNumber=73, createdTime=2017-12-21, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a774123956b5, moduleTitle=Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a774123956b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378153, encodeId=9db413e8153df, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案, objectType=article, longId=123151, objectId=925712315133, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=925712315133, replyNumber=0, likeNumber=24, createdTime=2017-12-14, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=925712315133, moduleTitle=【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=925712315133)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378152, encodeId=7d0413e815235, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期, objectType=article, longId=122722, objectId=f09b122e2259, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f09b122e2259, replyNumber=0, likeNumber=61, createdTime=2017-12-09, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f09b122e2259, moduleTitle=诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f09b122e2259)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378151, encodeId=526013e81517e, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Colorectal Dis：新辅助治疗方式对局部进展直肠癌患者生存期的影响, objectType=article, longId=122157, objectId=204012215ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=204012215ece, replyNumber=0, likeNumber=60, createdTime=2017-12-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=204012215ece, moduleTitle=Colorectal Dis：新辅助治疗方式对局部进展直肠癌患者生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=204012215ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378150, encodeId=0df713e8150fa, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期, objectType=article, longId=122135, objectId=146112213524, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=146112213524, replyNumber=0, likeNumber=79, createdTime=2017-12-04, rootId=0, userName=仁者大医, userId=8e886, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=146112213524, moduleTitle=2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=146112213524)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Radiology：胖不胖可能决定透明细胞肾癌患者整体生存期

2018-04-22

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Radiology：多参数MR成像预测非切除肝内胆管细胞型肝癌生存期的价值

2018-04-16

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Int Oral Max Surg：肿瘤PD-L1的表达与年轻女性口腔鳞状细胞癌生存期的改善及复发风险降低有关

2018-04-10

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

索拉非尼可改善纤维瘤患者的无进展生存期

2018-04-05

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Gastroenterology：巴雷特食管患者持续性内镜监控对生存期的影响

2018-03-02

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

J CLIN ONCOL :溶瘤病毒对抗脑瘤！临床1期显示：显著延长患者生存期

2018-03-01

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

FDA批准强生前列腺癌新疗法可延长生存期超2年

2018-02-27

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Lancet Haematol：改善CLL老年患者生存期：利妥昔单抗维持治疗 vs 观察治疗

2018-02-25

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

JAMA Neurol：1型肌营养不良患者生存期影响因素研究

2018-02-14

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Radiology：DSC MRI中胶质母细胞瘤血管征预测生存期的价值

2018-02-03

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Keytruda /化疗组合延长NSCLC患者的生存期

2018-01-20

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Circulation：他汀类药物对外周动脉疾病患者截肢和生存期的影响！

2018-01-14

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

BMJ：新辅助化疗可提高晚期上皮性卵巢癌3年生存期

2018-01-07

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

EUR J Cancer：阿司匹林与其他血小板聚集抑制剂对结直肠癌患者生存期的影响

2017-12-30

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Lancet Respir Med：救护车上给予抗菌药物能延长脓毒症患者的生存期吗？

2017-12-28

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Lancet：Atezolizumab不能延长PD-L1过表达的铂难治性转移性尿路上皮癌患者生存期

2017-12-21

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

【2017 ASH】RESONATE-2研究证实对于未经治疗的慢性淋巴细胞白血病患者，伊布替尼单药在延长无进展生存期和安全性方面均优于多种免疫化疗方案

2017-12-14

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

诺华kisqali表明可显著延长绝经前乳腺癌患者的无进展生存期

2017-12-09

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

Colorectal Dis：新辅助治疗方式对局部进展直肠癌患者生存期的影响

2017-12-04

仁者大医 (审核中...)

前往app查看评论内容

#生存期#

2017ASH前瞻：白血病组合疗法显疗效显著提高总生存期

2017-12-04

科室
- - 订阅+
  - 更多科室
工具
服务